Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
15 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
14 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the press release related to the full year 2021 financial results
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the full year 2021 financial results presentation
|
Download |
|
23 Feb 2022 |
About corporate governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
16 Nov 2021 |
On business and financial situation |
The Company releases the presentation related to its strategy update because of its 2021 Capital Markets Day
|
Download |
|
15 Nov 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 5 November 2021 and 12 November 2021
|
Download |
|
05 Nov 2021 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted on 3 and 4 November
|
Download |
|
03 Nov 2021 |
On business and financial situation |
The Company releases the first nine months 2021 financial results presentation
|
Download |
|
03 Nov 2021 |
On business and financial situation |
The Company releases the press release related to the first nine months 2021 financial results
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the presentation related to the full year 2018 results
|
Download |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the press release related to the full year 2018 results
|
Download |
|
15 Feb 2019 |
Others on business performance and financial information |
ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets
|
Download |
|
09 Jan 2019 |
Others on business performance and financial information |
ROVI informs about the adquisition of Falithrom® for the German market
|
Download |
|
08 Jan 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the fourth quarter of 2018
|
Download |
Pages
